Antibody Generation of ROS and Macular Degeneration
Antibody Generation of ROS and Macular Degeneration
批准号:
7273892
负责人:
PAUL WENTWORTH
金额:
$22.56万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2008-08-31
关键词:
AcidsAffectAgeAge related macular degenerationAntibodiesAntibody ActivationApoptosisApoptoticBiological AssayCell LineCell NucleusCell SurvivalCellsChemicalsChemosensitizationChronicDisease ProgressionEpithelialEpitopesEyeGenerationsHeat Shock Protein 27Heat shock proteinsHeat-Shock ResponseHousingHumanHydrogen PeroxideImmune systemImmunoglobulinsLaboratoriesLeadLightLipidsLipofuscinMacular degenerationMethodsMonitorMusNaphthaleneNaphthalenesNorthern BlottingNumbersOxidantsOxidative StressOxygenOxygen ConsumptionPathogenesisPathway interactionsPhotoreceptorsPhotosensitizing AgentsPlasmaPlayPrimary Cell CulturesProductionProteinsReactive Oxygen SpeciesResearch InstituteResearch PersonnelRetinaRetinalRetinal PigmentsRiboflavinRoleSamplingSerumSinglet OxygenSourceStaining methodStainsStructure of retinal pigment epitheliumSuperoxidesSurfaceTissuesUltraviolet RaysVisible RadiationWaterWhole Bloodabsorptionblindcaspase-3cell injurychromophorecross reactivitycytotoxicityirradiationmaculaoxidationperoxidationprogramsprotein foldingprotoporphyrin IXultraviolet
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the leading cause of blind registration in the developing world and yet its pathogenesis remains poorly understood. However, there is increasing evidence to support a role for the immune system and oxidative stress, arising from an imbalance in the production and destruction of reactive oxygen species (ROS) such as superoxide anion, hydrogen peroxide and singlet oxygen, in disease progression. There is also clear evidence that photochemical sensitization of chromophores stored within lipofuscin in the retinal pigment epithelial (RPE) cells via absorption of both ultraviolet and visible light, leads to ROS generation and damage in the ageing eye. We have recently shown that all antibody molecules, regardless of species or antigenic determinant, have an intrinsic ability to generate a cascade of potent oxidants when presented with either a chemical or photochemical source of singlet dioxygen. The end product of the antibody-catalyzed water-oxidation pathway (ACWOP) is hydrogen peroxide and thus the implication for this pathway to play a role in AMD via interception of photochemically generated singlet oxygen is a real possibility and would lead to an increase in overall oxidative stress. We intend to investigate this hypothesis with the three following specific aims: 1. Specific Aim #1 To determine whether oxidants generated by the ACWOP, are damaging to passaged human RPE cells or primary cultured human RPE cells, in terms of cytotoxicity, apoptosis and expression of heat shock protein (Hsp) 27. 2. Specific Aim #2 To determine whether the ACWOP can be activated by photoirradiation of A2E-loaded RPE cells and whether such activation enhances photochemical damage to these passaged and primary cultures of human RPE cells. 3. Specific Aim #3 To determine whether the ACWOP when activated in whole blood, plasma and serum can affect RPE cell survival
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
C3 Tumor Associated Carbohydrate Antigen Bioconjugates
-
批准号:8424948
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2012
-
负责人:PAUL WENTWORTH
-
依托单位:
C3 Tumor Associated Carbohydrate Antigen Bioconjugates
-
批准号:8301502
-
项目类别:
-
资助金额:$28.43万
-
财政年份:2012
-
负责人:PAUL WENTWORTH
-
依托单位:
C3 chemical conjugation to improve the anti-cocaine immune response
-
批准号:8233313
-
项目类别:
-
资助金额:$28.43万
-
财政年份:2011
-
负责人:PAUL WENTWORTH
-
依托单位:
C3 chemical conjugation to improve the anti-cocaine immune response
-
批准号:8092919
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2011
-
负责人:PAUL WENTWORTH
-
依托单位:
Lactobacilli surface antibody expression for in vivo protection against cholera
-
批准号:7772625
-
项目类别:
-
资助金额:$28.49万
-
财政年份:2010
-
负责人:PAUL WENTWORTH
-
依托单位:
Lactobacilli surface antibody expression for in vivo protection against cholera
-
批准号:8033092
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2010
-
负责人:PAUL WENTWORTH
-
依托单位:
Beauveriolide-Derived Cyclodepsipeptides as a New Class of Anti-Alzheimer's Drugs
-
批准号:7758245
-
项目类别:
-
资助金额:$19.98万
-
财政年份:2009
-
负责人:PAUL WENTWORTH
-
依托单位:
Investigating the link between the atheronals and aging
-
批准号:7273894
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2006
-
负责人:PAUL WENTWORTH
-
依托单位:
Investigating the link between the atheronals and aging
-
批准号:7124089
-
项目类别:
-
资助金额:$22.87万
-
财政年份:2006
-
负责人:PAUL WENTWORTH
-
依托单位:
Antibody Generation of ROS and Macular Degeneration
-
批准号:7096710
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2006
-
负责人:PAUL WENTWORTH
-
依托单位:
海外基金